Anemia, characterized by a decrease in the total number of erythrocytes or a decrease in the quality or quantity of hemoglobin, represents a significant diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive guide to the diagnostic approach to anemia for healthcare professionals.
The initial assessment should include a detailed patient history and physical examination. Symptoms such as fatigue, pallor, and dyspnea on exertion may suggest anemia. A family history of anemia or blood disorders can provide valuable clues to the diagnosis.
Complete blood count (CBC) is the primary laboratory test for anemia. It provides information on hemoglobin levels, red cell indices, and reticulocyte count. Further analysis of red cell size (mean corpuscular volume, MCV) can help differentiate between microcytic, normocytic, and macrocytic anemias, each with a distinct differential diagnosis.
Further diagnostic tools, such as iron studies, vitamin B12 and folate levels, bone marrow examination, and genetic testing, may be employed based on the initial findings. For example, iron studies can help diagnose iron deficiency anemia or anemia of chronic disease. Bone marrow examination may be necessary in cases of suspected hematologic malignancies or aplastic anemia.
In elderly patients, anemia can be a sign of underlying chronic disease or malignancy. In women of childbearing age, iron deficiency anemia due to menstrual blood loss is common. Therefore, the diagnostic approach should be tailored according to the patient's age, sex, and overall health status.
In conclusion, the diagnostic approach to anemia involves a stepwise process starting with a comprehensive history and physical examination, followed by laboratory investigations and advanced diagnostic tools if needed. Understanding the complexity of anemia is crucial for its effective diagnosis and management.
1.
New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations
2.
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC
3.
In early dementia, SSRIs enhance cognition and major depression.
4.
The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.
5.
Early breast cancer detection may be possible with a wearable ultrasound scanner.
1.
Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling
2.
Tumor Evolution: Signaling, Plasticity, and Intratumor Heterogeneity in Cancer
3.
Essential Perspectives in Hematology and Patient Outcomes
4.
Decoding Hamartomas: Understanding Their Causes and Symptoms
5.
Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
5.
Signs and Symptoms of Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation